Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
June 25, 2014 08:31 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Jun 25, 2014) - Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5...
Orgenesis Awarded Maryland Stem Cell Research Fund Grant
May 29, 2014 14:16 ET
|
Orgenesis Inc.
GERMANTOWN, MD--(Marketwired - May 29, 2014) - Orgenesis Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into...
Orgenesis Appoints Joseph Tenne as Chief Financial Officer
April 21, 2014 08:31 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Apr 21, 2014) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...
Orgenesis Secures $3 Million in Funding From Kodiak Capital Group
December 18, 2013 11:01 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Dec 18, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...
Orgenesis CSO & Founder, Dr. Sarah Ferber, to Present at the 2013 World Stem Cell Summit on December 4
December 03, 2013 17:03 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Dec 3, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...
Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cells
November 05, 2013 08:31 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwired - Nov 5, 2013) - Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver...
Orgenesis to Present at the 2013 Gateway Conference on September 10
September 04, 2013 17:15 ET
|
Orgenesis Inc.
SAN FRANCISCO, CA--(Marketwired - Sep 4, 2013) - Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...
Orgenesis Inc. Increases Depth of Governance With Latest Board Appointee
May 08, 2012 09:00 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwire - May 8, 2012) - Orgenesis Inc. (OTCBB: ORGS) ("Orgenesis" or the "Company"), a development stage company with a novel therapeutic technology dedicated to convert a...
Orgenesis Inc. Appoints Experienced Pubco Development Professional to Board of Directors
April 30, 2012 09:00 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwire - Apr 30, 2012) - Orgenesis Inc. (OTCBB: ORGS) ("Orgenesis" or the "Company"), a development stage company with a novel therapeutic technology dedicated to convert a...
Orgenesis Inc. Appoints Ex FDA Officer and Diabetes Authority to Scientific Advisory Board
April 23, 2012 09:00 ET
|
Orgenesis Inc.
WHITE PLAINS, NY--(Marketwire - Apr 23, 2012) - Orgenesis Inc. (OTCBB: ORGS) ("Orgenesis" or the "Company"), a development stage company with a novel therapeutic technology dedicated to convert a...